Neoangiogenic transcriptomic signature identifies HCCs with worse response to treatment: long-term results of a prospective study. (February 2020) - Pivetti, A.; Borghi, A.; Critelli, R.; Lei, B.; Casari, F.; Del Buono, M.; Milosa, F.; Bianchini, M.; Caporali, C.; Bernabucci, V.; De Maria, N.; Di Benedetto, F.; et al.